Is FSTX or RYLD a better dividend investment in 2026?

FSTX currently yields 28.09% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: FSTX offers higher current income.

What is the dividend yield difference between FSTX and RYLD?

FSTX has a forward dividend yield of 28.09% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 15.95 percentage points.

Home › Compare › FSTX vs RYLD

FSTX vs RYLD: Dividend Comparison 2026

FSTX yields 28.09% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 FSTX wins by $74.0K in total portfolio value

INVESTMENT

TIME HORIZON10 years

FSTX

● Live price

28.09%

Share price

$7.12

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$118.5K

Annual income

$14,804.06

Full FSTX calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — FSTX vs RYLD

📍 FSTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	FSTX	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, FSTX + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

FSTX pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FSTX

Annual income on $10K today (after 15% tax)

$2,387.64/yr

After 10yr DRIP, annual income (after tax)

$12,583.45/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, FSTX beats the other by $10,384.20/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FSTX + RYLD for your $10,000?

FSTX: 50%RYLD: 50%

100% RYLD50/50100% FSTX

Portfolio after 10yr

$81.5K

Annual income

$8,695.70/yr

Blended yield

10.67%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on FSTX right now

FSTX

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

0.7

Piotroski

3/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FSTX buys

RYLD buys

No recent congressional trades found for FSTX or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricFSTXRYLD

Forward yield	28.09% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$118.5K ✓	$44.5K
Annual income after 10y	$14,804.06 ✓	$2,587.35
Total dividends collected	$78.8K ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: FSTX vs RYLD ($10,000, DRIP)

Year	FSTX Portfolio	FSTX Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$13,509	$2,808.99	$11,914	$1,213.65	+$1.6K → FSTX
2	$18,001	$3,546.41	$14,099	$1,351.30	+$3.9K → FSTX
3	$23,678	$4,416.52	$16,580	$1,494.55	+$7.1K → FSTX
4	$30,764	$5,429.21	$19,384	$1,642.61	+$11.4K → FSTX
5	$39,510	$6,592.67	$22,535	$1,794.70	+$17.0K → FSTX
6	$50,189	$7,913.03	$26,063	$1,950.00	+$24.1K → FSTX
7	$63,097	$9,394.15	$29,995	$2,107.69	+$33.1K → FSTX
8	$78,551	$11,037.47	$34,361	$2,266.99	+$44.2K → FSTX
9	$96,891	$12,841.93	$39,194	$2,427.12	+$57.7K → FSTX
10	$118,478	$14,804.06	$44,525	$2,587.35	+$74.0K → FSTX

FSTX vs RYLD: Complete Analysis 2026

FSTX — Stock

F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck cancer patients. It is also developing first-in-human clinical study of FS222, a bispecific antibody that is in Phase 1 clinical trial targeting the costimulatory CD137 receptor and the inhibitory PD-L1 ligand. In addition, the company is also evaluating FS120 and SB 11285 for patients with advanced cancers, which are under Phase 1 clinical trials. F-star Therapeutics, Inc. was incorporated in 2002 and is headquartered in Cambridge, the United Kingdom.

Full FSTX Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this FSTX vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FSTX vs SCHD FSTX vs JEPI FSTX vs O FSTX vs KO FSTX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.